These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 29153305)

  • 41. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
    El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
    Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trial.
    Gupta S; Zhou P; Hassoun H; Kewalramani T; Reich L; Costello S; Drake L; Klimek V; Dhodapkar M; Teruya-Feldstein J; Hedvat C; Kalakonda N; Fleisher M; Filippa D; Qin J; Nimer SD; Comenzo RL
    Bone Marrow Transplant; 2005 Mar; 35(5):441-7. PubMed ID: 15640822
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peripheral blood stem cell transplants.
    Byrne JL; Russell NH
    J Clin Pathol; 1998 May; 51(5):351-5. PubMed ID: 9708199
    [No Abstract]   [Full Text] [Related]  

  • 44. Poor mobilization status: a lingering legacy for allograft recipients.
    Herbert K; Ritchie D
    Leuk Lymphoma; 2013 Feb; 54(2):227-8. PubMed ID: 22906189
    [No Abstract]   [Full Text] [Related]  

  • 45. Chemo-Mobilization in Myeloma-Diminishing Returns in the Era of Novel Agent Induction?
    Hari P
    Biol Blood Marrow Transplant; 2018 Feb; 24(2):203-204. PubMed ID: 29272697
    [No Abstract]   [Full Text] [Related]  

  • 46. Autologous hematopoietic stem cell transplantation activity for lymphoma and multiple myeloma in China.
    Liu W; Ji J; Zou D; Cao Y; Xu Y; Zhou J; Gao S; Wang F; Chen W; Du J; Zhou H; Zhou F; Shi J; Zhang X; Yang J; Jing H; Jiang Z; Liu H; Li C; Peng H; Jiang S; Wei X; He P; Liu Y; Yang H; Li Z; Huang X; Liu L; Shen L; Liu C; Song Y; Qiu L; Wang X; Ma J; Zhu J
    Bone Marrow Transplant; 2023 Mar; 58(3):349-352. PubMed ID: 36528754
    [No Abstract]   [Full Text] [Related]  

  • 47. Bibliography. Current world literature. Lymphoma.
    Curr Opin Oncol; 2002 Sep; 14(5):546-66. PubMed ID: 12356007
    [No Abstract]   [Full Text] [Related]  

  • 48. Chemomobilization: Overview of an Educational Quality Improvement Project for Recipients of Autologous Stem Cell Transplantation.
    Rivera ZR; Nurse R; Fellman B; Brunelle N; Brassil KJ
    Clin J Oncol Nurs; 2017 Aug; 21(4):E106-E113. PubMed ID: 28738047
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Asia-Pacific Hematology Consortium Report on approach to multiple myeloma. Survey results from the 6th International Hematologic Malignancies Conference: Bridging the Gap 2015, Beijing, China.
    Lu J; Hou J; Liu KY; Parmar S; De La Fuente A; Andersson B; Yan C; Zhou D; Tan D; Ritchie D; Wu D; Shpall E; Laport GG; Li J; Hu J; Zhang LS; Wang M; Malhotra P; Jiang Q; Qin Y; Wong R; Champlin R; Issaragrisil S; Iyer S; Mathews V; Wang Y; Hu Y; Xiao Z; Shao Z; Rosengarten R; Steuernagle J; Xiao JH; Orlowski R; Chim CS
    Leuk Lymphoma; 2016 Jul; 57(7):1534-8. PubMed ID: 26887657
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peripheral hematopoietic progenitor cell mobilization for autologous transplantation in hematologic malignancies.
    Marques JF
    Rev Bras Hematol Hemoter; 2011; 33(6):400-1. PubMed ID: 23049350
    [No Abstract]   [Full Text] [Related]  

  • 51. A survey on the patient perspective on cure in multiple myeloma.
    Mohyuddin GR; Ahlstrom JM; Chmielewski CA; Sweeney NW; Molina TH; Cheung CS; Ballard EW; Seng FF; Van Oekelen O; Godara A; McClune B; Sborov D
    Lancet Haematol; 2022 Oct; 9(10):e716-e719. PubMed ID: 36174636
    [No Abstract]   [Full Text] [Related]  

  • 52. Autologous hematopoietic progenitor cell mobilization and collection in adult patients presenting with multiple myeloma and lymphoma: A position-statement from the Turkish Society of Apheresis (TSA).
    Tekgündüz E; Arat M; Göker H; Özdoğu H; Kaynar L; Çağırgan S; Erkurt MA; Vural F; Kiki İ; Altuntaş F; Demirkan F;
    Transfus Apher Sci; 2017 Dec; 56(6):845-849. PubMed ID: 29153306
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcome and survival of myeloma patients diagnosed 2008-2015. Real-world data on 4904 patients from the Swedish Myeloma Registry.
    Blimark CH; Turesson I; Genell A; Ahlberg L; Björkstrand B; Carlson K; Forsberg K; Juliusson G; Linder O; Mellqvist UH; Nahi H; Kristinsson SY;
    Haematologica; 2018 Mar; 103(3):506-513. PubMed ID: 29217784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population.
    Sørrig R; Klausen TW; Salomo M; Vangsted AJ; Frølund UC; Andersen KT; Klostergaard A; Helleberg C; Pedersen RS; Pedersen PT; Helm-Petersen S; Teodorescu EM; Preiss B; Abildgaard N; Gimsing P;
    PLoS One; 2017; 12(12):e0188988. PubMed ID: 29216227
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinicopathological Characteristics of Hyperdiploidy with High-Risk Cytogenetics in Multiple Myeloma.
    Yang N; Mun YC; Seong CM; Huh HJ; Huh J
    Ann Lab Med; 2018 Mar; 38(2):160-164. PubMed ID: 29214761
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma.
    de la Puente P; Luderer MJ; Federico C; Jin A; Gilson RC; Egbulefu C; Alhallak K; Shah S; Muz B; Sun J; King J; Kohnen D; Salama NN; Achilefu S; Vij R; Azab AK
    J Control Release; 2018 Jan; 270():158-176. PubMed ID: 29196043
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current status of art mobilization in Myeloma.
    Sevindik OG; Korkmaz S; Altuntas F
    Transfus Apher Sci; 2017 Dec; 56(6):850-853. PubMed ID: 29174798
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and efficacy of pomalidomide, dexamethasone and pegylated liposomal doxorubicin for patients with relapsed or refractory multiple myeloma.
    Cohen A; Spektor TM; Stampleman L; Bessudo A; Rosen PJ; Klein LM; Woliver T; Flam M; Eshaghian S; Nassir Y; Maluso T; Swift RA; Vescio R; Berenson JR
    Br J Haematol; 2018 Jan; 180(1):60-70. PubMed ID: 29164606
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early Relapse for Multiple Myeloma Patients Undergoing Single Autologous Stem Cell Therapy: A Single-center Experience.
    Lee H; Duggan P; Chaudhry A; Neri P; Tay J; Rashid-Kolvear F; Bahlis NJ; Jimenez-Zepeda VH
    Clin Lymphoma Myeloma Leuk; 2018 Jan; 18(1):e69-e75. PubMed ID: 29158114
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autologous stem cell transplantation and stem cell mobilization kinetics in elderly patients with B cell non-Hodgkin lymphoma.
    Dogu MH; Çagirgan S; Ocakci S; Kaya AH; Ilkkilic K; Sanli NM; Kahraman S; Eren R; Tekgunduz E; Hacioglu S; Kaynar L; Erkurt MA; Altuntas F
    Transfus Apher Sci; 2017 Dec; 56(6):814-818. PubMed ID: 29153347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.